Paul McBarron

Insider Reports History

Location
Berkeley Heights, NJ
Signature
/s/ Paul McBarron
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul McBarron:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. E. VP, Fin, CFO, COO and Secretary, Director Common Stock 33,378 $110,648 $3.32 21 Dec 2023 Direct
Cyclacel Pharmaceuticals, Inc. E. VP, Fin, CFO, COO and Secretary, Director Stock Option (right to buy) 70,200 30 Jun 2023 Direct
Cyclacel Pharmaceuticals, Inc. E. VP, Fin, CFO, COO and Secretary, Director Warrants (right to buy) 1,886 21 Dec 2023 Direct

Insider Reports Filed by Paul McBarron

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CYCC Cyclacel Pharmaceuticals, Inc. 21 Dec 2023 2 +$6,252 4 E. VP, Fin, CFO, COO and Secretary, Director 26 Dec 2023, 16:05
CYCC Cyclacel Pharmaceuticals, Inc. 30 Jun 2023 1 $0 4 E. VP, Fin, CFO, COO and Secretary, Director 03 Jul 2023, 16:57
CYCC Cyclacel Pharmaceuticals, Inc. 31 Jan 2023 1 $0 4 E. VP, Fin, CFO, COO and Secretary, Director 02 Feb 2023, 15:19
CYCC Cyclacel Pharmaceuticals, Inc. 13 Dec 2021 1 $0 4 E. VP, Fin, CFO, COO and Secretary, Director 15 Dec 2021, 15:19